Mounjaro Tracker: What to Track on Mounjaro & How (2026)
This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition.
Quick answer
A Mounjaro tracker logs your dose date, injection site, weight trend, protein & side effects. Learn exactly what to track on tirzepatide and why it matters.
Mounjaro (tirzepatide) is a once-weekly injectable that is unusual among these medicines: it is a dual agonist, acting on two gut hormones — GIP and GLP-1 — where semaglutide (Ozempic, Wegovy) acts on GLP-1 alone.
In the US, Mounjaro is FDA-approved for type 2 diabetes; the same molecule is sold as Zepbound for chronic weight management. That Mounjaro/Zepbound split is the US picture.
In the EU, Brazil, China and a number of other countries there is no Zepbound brand: Mounjaro itself is approved for both type 2 diabetes and weight management (EU product information; Brazil's ANVISA, June 2025; China's NMPA, July 2024).
Either way, it works slowly over months on a dose that climbs on a fixed calendar — which makes it exactly the kind of treatment that rewards good record-keeping.
This guide covers what to track on Mounjaro, why each item matters clinically, and how to turn it into a two-minute weekly routine.
It is neutral and educational: you can do all of it on paper. An app just automates the parts people forget.
If you are weighing Mounjaro against other GLP-1s or want the general framework first, start with our complete GLP-1 tracker app guide, then come back here for the Mounjaro-specific details.
01
Why tracking matters on Mounjaro specifically
Three things about Mounjaro make tracking more than a nice-to-have:
The dose escalates on a schedule, across six steps.
Mounjaro starts low and steps up every four weeks, from 2.5 mg all the way to a possible 15 mg. That is more dose changes than most GLP-1s, so logging which dose you took on which date keeps you synced to the plan and gives your prescriber an exact history at every adjustment visit.
It is once weekly, so a miss is easy.
A single skipped or late shot is far more likely with a weekly medicine than a daily one. A timestamped log makes the missed-dose decision simple instead of stressful (see the 4-day rule below).
Results and side effects are non-linear.
Weight and blood sugar move in fits and plateaus, and nausea tends to spike right after each dose increase. Only a trend — not a single day — tells you what is actually happening.
02
What to track on Mounjaro (and why each one matters)
Here is the core Mounjaro dataset. Use it as your checklist whether you track on paper, in a spreadsheet, or in an app.
Dose date and your Mounjaro titration schedule
Mounjaro is deliberately started low and increased in 2.5 mg steps every four weeks to reduce gastrointestinal side effects.
Per Eli Lilly's dosing guidance, the escalation is 2.5 mg (weeks 1–4, a starting dose only) → 5 mg (weeks 5–8) → and then, if more control is needed, 7.5 mg → 10 mg → 12.5 mg → 15 mg maintenance, each step held for at least four weeks (Lilly HCP dosing; Mounjaro prescribing information).
Because the dose changes on a calendar and there are up to six levels, logging which mg you took on which date is the single most useful thing you can record.
Many people stay at a dose below 15 mg if it controls their numbers and is tolerated — your prescriber decides, and a clean dose log makes that conversation faster.
The missed-dose rule (worth getting right). Mounjaro uses a 4-day (96-hour) rule, which is shorter than semaglutide's 5-day window (Ozempic; Wegovy's US "next dose more than 2 days away" wording describes the same window) — a common point of confusion.
Per Lilly: if it has been 4 days (96 hours) or less since your missed dose, take it as soon as possible; if more than 4 days have passed, skip it and take the next dose on your regular day.
You can also move your weekly day as long as your doses stay at least 3 days (72 hours) apart (Lilly medical information).
A tracker that timestamps every shot turns this into a glance.
Injection site and rotation
Mounjaro is injected subcutaneously into one of three areas: the abdomen (keep clear of the navel), the front of the thigh, or the upper arm, rotating each week (Mounjaro medication guide).
Repeatedly injecting the same exact spot can cause lipohypertrophy — lumpy scar tissue that changes how the medicine is absorbed.
The problem is memory: after a few weeks, nobody recalls "left thigh or right arm last time?" This is where a tracker earns its keep — a good one shows a body map with your recent sites highlighted so you always pick a fresh one.
Weight, measurements, and progress photos
Weight is the headline number for a Mounjaro weight loss tracker, but it is noisy day to day.
Weigh in at the same time (typically morning, after the bathroom, before eating) and let the trend line — not a single reading — tell the story.
Plateaus are common and medically explainable.
Waist measurements and progress photos every 2–4 weeks capture body-composition change the scale hides, which matters most exactly when the number stalls.
If you are using Mounjaro for type 2 diabetes, your blood-sugar log belongs right next to your weight trend.
Protein, food, and protecting muscle
This is the most under-appreciated part of a Mounjaro journey.
Because tirzepatide sharply reduces appetite, a meaningful share of the weight you lose can be lean body mass — in the body-composition substudy of the SURMOUNT-1 trial, about 25% of the weight lost on tirzepatide was lean mass and about 75% was fat (note that lean mass includes water and organ tissue, not only skeletal muscle) (Look et al., Diabetes, Obesity and Metabolism, 2025).
Muscle protects your metabolism and long-term results. Two trackable habits do the heavy lifting:
- Protein. Aim for a high-protein target at each meal (many clinicians suggest distributing protein across the day). When appetite drops, protein is usually the first thing to fall — so logging it keeps it front of mind.
- Resistance training. Strength work is the strongest defense against muscle loss on a GLP-1 or dual agonist; log your sessions like you log your dose.
Side effects — normal vs. red flag
The most common Mounjaro side effects are gastrointestinal: nausea, diarrhea, vomiting, constipation, reduced appetite, and indigestion.
These usually appear or worsen right after a dose increase and settle as your body adapts.
Rare but serious risks include pancreatitis, gallbladder disease, and — because Mounjaro can lower blood sugar, especially with insulin or a sulfonylurea — hypoglycemia; all need prompt medical assessment.
Logging what you felt, how severe, and how many days since your last dose or dose step-up turns a vague "I've felt off" into a clear pattern.
For the full symptom-by-symptom breakdown, see our guide to Mounjaro side effects.
If you use birth-control pills: the US tirzepatide labels (Mounjaro, Zepbound) advise switching to a non-oral method or adding a barrier method for 4 weeks after starting and for 4 weeks after each dose increase.
The EU label does not require this, so ask your prescriber which applies to you.
Safety basics for any GLP-1 log. Don't use these medicines if you or a close relative has had medullary thyroid cancer, or if you have MEN 2.
They are not used during pregnancy — tell your prescriber right away if you become pregnant or plan to, because some must be stopped weeks to months beforehand.
If you also take insulin or a sulfonylurea, watch for low blood sugar (shakiness, sweating, confusion).
Vomiting or diarrhea that keeps you from holding down fluids can dehydrate you and strain your kidneys — call your clinician.
A tracker organizes your records; the package leaflet in your country and your prescriber come first.
| What to track | Why it matters | How often |
|---|---|---|
| Dose date & amount (mg) | Keeps you aligned with the six-step titration; confirms adherence; prevents accidental double-dosing | Every injection (weekly) |
| Injection site & rotation | Rotating sites prevents lumpy scar tissue (lipohypertrophy) that changes drug absorption | Every injection |
| Body weight | A primary outcome; the trend reveals plateaus and metabolic adaptation | 1–3× per week, same time of day |
| Blood sugar (if T2D) | Mounjaro is a diabetes medicine first; fasting/post-meal readings show how it is working | As advised by your care team |
| Waist / measurements | Catches fat loss the scale misses, especially while preserving muscle | Every 1–2 weeks |
| Protein intake (grams) | Protects lean muscle mass, which is at risk during rapid weight loss | Daily |
| Water / hydration | Eases the constipation and nausea common in the first weeks | Daily |
| Side effects & severity | Separates normal adaptation from red-flag symptoms needing a doctor | As they occur |
| Progress photos | Visual proof of body-composition change when the scale stalls | Every 2–4 weeks |
| Refill / pen supply | A weekly injectable runs out on a predictable date; avoids a coverage gap | Monthly |
03
How to build a Mounjaro tracking routine in 6 steps
You do not need a complicated system — you need a repeatable one. This takes under two minutes a week for the core log, plus quick daily taps.
- 1
Set a weekly injection reminder.
Pick a consistent day and time and set a recurring alert so a late shot never sneaks up on you.
- 2
Log the dose and site right after injecting.
Record the mg amount and mark the body-map zone, so next week's rotation is obvious.
- 3
Weigh in on fixed days.
Choose 1–3 mornings a week, same conditions, and read the trend — not the daily noise. Add blood-sugar readings if you have diabetes.
- 4
Track protein and water daily.
A quick tap per meal is enough to keep muscle protection on track.
- 5
Note side effects when they happen.
Record the symptom, severity, and days since your last dose or dose increase.
- 6
Photo every 2–4 weeks and review before each visit.
Same lighting, same angle — and bring your dose log and side-effect timeline to your clinician.
04
Do you need a Mounjaro app, or is a notebook fine?
Honestly, any tracking beats none — a Mounjaro diary in a notebook works.
What an app adds is the automation of the parts people forget: the weekly reminder, the injection-site rotation map, the trend line that smooths daily weight noise, and a side-effect timeline you can hand to your clinician.
Mounjaro does not ship with a dedicated companion app, so most people use a general GLP-1 or wellness tracker.
If you want your dose log living next to the daily habits that protect your results — protein, movement, hydration, weight and body-composition trends — a wellness app like HAVIT is a natural home for it.
Compare a few options in our best GLP-1 tracker apps guide and pick what you will actually keep using; consistency matters far more than the brand.
05
Related guides
- Mounjaro side effects: nausea, GI symptoms & red flags
- Weight loss tracker: how to track fat loss, not just the scale
- Best GLP-1 tracker app alternatives compared
- The complete GLP-1 tracker app guide
06
Why HAVIT — Medication + Behavior Change, in One App
GLP-1 medications can meaningfully reduce weight — but the number on the scale is only part of the story.
Depending on the study, lean (non-fat) tissue has accounted for anywhere from about 15% to more than 40% of the weight lost on GLP-1-based therapy (Neeland et al., Diabetes, Obesity and Metabolism, 2024), and results tend to fade once the medication stops unless new habits take their place.
That's why leading guidance treats medication as one part of care, not the whole: the U.S. Preventive Services Task Force recommends that adults with obesity be offered intensive, multicomponent behavioral interventions (USPSTF, Grade B).
HAVIT is built for exactly this moment — one app that unites medication tracking, body composition, nutrition and protein, daily habit-building, and an AI coach that adapts to you.
Across our own 1,090 GLP-1 users, the most consistent trackers built the strongest habits (see the GLP-1 habit report).
Manage the medicine and the muscle — together. Start with HAVIT →
Frequently asked questions
What is a Mounjaro tracker?
What should I track on Mounjaro?
What is the Mounjaro dose schedule I should log?
What happens if I miss a Mounjaro dose?
Why do I need to track my Mounjaro injection site?
Is Mounjaro the same as Zepbound?
Why is protein tracking so important on Mounjaro?
Is there an official Mounjaro tracking app?
What is HAVIT?
HAVIT is an AI health partner built on metabolic science — it protects your muscle, wakes up your metabolism, and helps you keep a healthy, rebound-free body for the long run.
Unlike calorie-only trackers, HAVIT connects AI body-composition estimates, nutrition, hydration, sleep, steps, cycle, mood, and GLP-1 medication in one daily routine — so progress is measured by body composition, not just the number on the scale. Daily missions turn established behavior-change techniques into small repeatable actions, drawing on expertise from professionals formerly at Juvis Diet, one of Korea’s leading metabolic clinics.
In HAVIT’s own analysis of 1,090 GLP-1 users, people who logged consistently built stronger habits than the general user base. Read the GLP-1 Habit Report
Inside the app
- AI COACHA coach that reads your day.
- NUTRITIONLog meals in seconds.
- BODY INSIGHTSSee more than weight.
- DAILY MISSIONSBuild habits you can repeat.
- DAILY CHECK-INTell HAVI how today feels.
- TRACK EVERYTHINGFrom water to GLP-1
- MIND & RECOVERYFor the days willpower runs out.
HAVIT works with or without GLP-1 medication. It is a wellness app, not a medical device; body-composition results are estimates.
Continue in the App
Personalized wellness with your own data
References
- MOUNJARO (tirzepatide) injection — US prescribing information dailymed.nlm.nih.gov
- Mounjaro (tirzepatide) Medication Guide — injection sites and use pi.lilly.com
- How should Mounjaro (tirzepatide) doses be increased in adults? (dose escalation and missed doses) medical.lilly.com
- Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight doi.org
- Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies doi.org
- GLP-1 agonists and exercise: the future of lifestyle prioritization doi.org
- Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults doi.org
- EMA — Mounjaro EPAR product information (4.1 indications incl. weight management) ema.europa.eu
- Conselho Federal de Farmácia — Anvisa aprova Mounjaro para tratamento de obesidade e sobrepeso no Brasil, Jun 9, 2025 site.cff.org.br
- BioSpace — Lilly wins Chinese approval for tirzepatide in obesity (NMPA, Jul 2024) biospace.com
- Eli Lilly — MOUNJARO prescribing information (7.2 oral contraceptives) pi.lilly.com
